Daily Morning Note – 25 February 2019


Register HERE forMONDAY’s 11.15am webinar.

Archived webinars available.


President Donald Trump said he’s extended a deadline to raise tariffs on Chinese goods until he can meet Chinese President Xi Jinping after the two sides made “substantial progress” in the latest round of trade talks that wrapped up Sunday. If the sides make further progress, Trump said he and Xi planned to meet in Mar-a-Lago to conclude an agreement, though he didn’t specify the timing around it. The U.S. and China are currently stuck on how to ensure Beijing lives up to its promise it won’t weaken the yuan as part of a trade deal, according to people familiar. There are several ways China influences its currency, such as driving up the cost of betting against the currency in Hong Kong and the central bank’s daily fixing. Secretary Steven Mnuchin said the two sides agreed on a currency provision and China’s Liu He voiced optimism that an accord would be reached. Meanwhile, U.S. President Donald Trump is becoming frustrated with his top negotiator, Robert Lighthizer.


China Everbright Water Limited – Steady and healthy growth

Recommendation: BUY ; Last close: S$0.355

Target Price: S$0.48, Analyst: Chen Guangzhi

– As of Jan-19, CEWL has a portfolio of 118 projects, 87 are operating, 13 under construction and 13 in the preparatory stage..

– CEWL Increased dividend to 0.99 SG cents in FY18 (FY17: 0.49 SG cents).

– Secured more funding with relatively low costs.

United Overseas Bank Limited – Profit momentum to continue

Recommendation: BUY (Maintained); Last close: S$25.58

Target Price: S$32.50, Analyst: Tin Min Ying

– FY18 revenue and PATMI were in line with our expectations.

– FY18 NIM rose 5bps YoY to 1.82%; but 4Q18 NIM contracted 1bps QoQ to 1.80% due to the rise in cost of funds and time lag in repricing.

– Loan growth of 10.9% YoY was led by broad-based increase across all territories and industries.

– Allowances declined 46% YoY due to benign credit environment; and NPL improved to 1.5% (FY17: 1.8%).

– Proposed higher final dividend of 50 cents per share and special dividend of 20 cents per share. This brings full year dividend to $1.20 per share (FY17: $1.00).

– Maintain BUY with an unchanged target price of S$32.50.

Oversea-Chinese Banking Corp Ltd – Further upside for NIM expansion

Recommendation: BUY (Maintained), Last Close Price: S$11.39

Target Price: S$13.70, Analyst: Tin Min Ying

– FY18 revenue and PATMI missed our estimates by 3.5% and 5.2% respectively due to a decline in net gains from investment securities and other income.

– FY18 NIM met our expectations by expanding 5 bps YoY to 1.70%.

– FY18 loans grew 8.6% YoY, driven by Building & Construction (+51.2% YoY) and Greater China loans (+8.9% YoY).

– FY18 NPL ratio remained stable at 1.5% (FY17: 1.4%); while credit costs normalised to 11 bps (FY17: 27 bps).

– Proposed final dividend increased to 23 cents per share, bringing full-year dividend to 43 cents per share (FY17: 37cents per share.

– Maintain BUY with an unchanged target price of S$13.70.

Source: Bloomberg; PSR


Sarine Technologies has recorded a fourth-quarter net profit of US$93,000, down 84.8 per cent from US$613,000 the year before, the diamond technologies company said in a regulatory filing on Monday before the market opened.

Raffles Medical Group has posted a net profit of S$71.1 million for 2018, up 0.4 per cent from S$70.8 million for 2017as a 7.8 per cent rise in Ebitda (earnings before interest, taxes, depreciation, and amortisation) was offset by higher tax expense and additional depreciation from the recently completed Raffles Specialist Centre in Singapore.Revenue for the 12 months ended Dec 31 was S$489.1 million, up 2.4 per cent from S$477.6 million for 2017.

Dasin Retail Trust which holds four malls in Zhongshan city in China’s Guangdong province, on Sunday posted its distribution per unit (DPU) for its fourth quarter that slightly beat its forecast for the quarter by0.9 per cent. DPU for the three months ended Dec 31, 2018 stood at1.83 Singapore cents, up from a projected 1.81 Singapore cents. This DPU takes into account a “distribution waiver”, through which major unitholders -Aqua Wealth Holdings Limited and Bounty Way -have waived a portion of their entitlement to distributions from Dasin Retail Trust. The total amount of the waived distribution has been distributed to the rest of the unitholders.

Best World Internationa is hiring an independent reviewer to scrutinise its business and accounting practices, afterThe Business Timesraised concerns last week over the challenges in tracking sales of its DR’s Secret line of premium skincare products in China. In astatement on Saturday, the company told shareholders that it has conducted its business ethically and in compliance with applicable laws, but “is not responsible for the accounting and sales records of the franchisees, who are independent third parties.”

Source: Business Times

Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: www.poems.com.sg > STOCKS > Research

Read the research report(s), available through the link(s) above, for complete information including important disclosures

Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com